Publication | Closed Access

The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma

Tumor BiologyExpression LevelsUrologyGenitourinary CancerOncogenic AgentMedicineIncreased Transglutaminase 2Renal Cell CarcinomaCancer BiologyRadiation OncologyTumor MicroenvironmentCancer Research